What is NeoGenomics's debt repayments?

NeoGenomics (NEO) reported debt repayments of $50.31M in Q4 2025.

What does debt repayments mean?

Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.

NeoGenomics NEO Debt Repayments

Debt Repayments at other companies

Myriad GeneticsMYGN

$0-100%

Labcorp HoldingsLH

$0-100%

Quest DiagnosticsDGX

$500M+24.7%

Biodesix, Inc.BDSX

$5K-28.6%

Fulgent Genetics, Inc.FLGT

$476K+1.3%

GeneDx HoldingsWGS

$2M—

Other financials

Income statement

See full

Revenue$201.7M+11.2%

Gross profit$91.9M+18.9%

Operating income-$9.8M+79.5%

Net income$2.2M+105%

EPS (diluted)$0.02+106%

Balance sheet

See full

Cash & equivalents$145.5M-5.9%

Total debt$448.4M+534%

Total equity$785.7M-8.0%

Total assets$1.4B-3.0%

Cash flow

See full

Operating cash flow$20.0M-1.8%

CapEx$8.2M+30.0%

Free cash flow-$13.1M+56.0%

Valuation

See full

Market cap$1.74B+158%

Enterprise value$2.05B+246%

P/S2.3×+1.3×

Profitability

See full

Gross margin43.9%0.0pp

Operating margin-8.9%-2.8pp

Net margin-6.8%-2.4pp

FCF margin-4.9%—

Returns & leverage

See full

Return on equity-6.3%-2.0pp

Debt / equity0.6×+0.5×

Current ratio3.6×-0.3×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfConvertibleDebt.

The official record: NeoGenomics’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NeoGenomics's debt repayments?: NeoGenomics (NEO) reported debt repayments of $50.31M in Q4 2025.
What does debt repayments mean?: Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.